DDD pacemaker for severe heart failure-alternate to CRT

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Severe systolic heart failure significantly impacts patient quality of life and survival despite optimal medical treatment.
• Cardiac Resynchronization Therapy (CRT) is an established treatment for heart failure patients with specific electrocardiographic (ECG) criteria, including left bundle branch block (LBBB).
• High costs associated with CRT limit access for many eligible patients.

Observation:

• Patients with severe systolic heart failure and LBBB often have suboptimal outcomes with medical management alone.
• The effectiveness of CRT in improving outcomes for this patient group is well-documented.
• Financial constraints present a significant barrier to CRT adoption.

Findings:

• Dual chamber pacing (DDD) utilizing right atrial and isolated left ventricular pacing (RA-LV) presents a potentially more cost-effective alternative to CRT.
• This RA-LV pacing strategy warrants further investigation as a viable option for selected heart failure patients.

Implications:

• Implementing cost-effective pacing strategies like RA-LV could broaden access to beneficial therapies for heart failure patients.
• Further research is needed to compare the efficacy and long-term outcomes of RA-LV pacing versus standard CRT.
• Exploring alternative pacing configurations can address healthcare economic challenges in managing severe systolic heart failure.